Suppr超能文献

成人急性秋水仙碱中毒的处理进展。

Progress in the management of acute colchicine poisoning in adults.

机构信息

Department of Emergency Medicine, Shengjing Hospital of China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, 110004, Liaoning, China.

出版信息

Intern Emerg Med. 2022 Oct;17(7):2069-2081. doi: 10.1007/s11739-022-03079-6. Epub 2022 Aug 26.

Abstract

Colchicine is a tricyclic, lipid-soluble alkaloid which has long been used to treat gout and many immunological diseases. Due to its narrow therapeutic window and long half-life of elimination, colchicine overdose occurs occasionally. Unfortunately, some patients lost their lives because of colchicine overdose or suicide. Acute colchicine poisoning can lead to original gastrointestinal disorders, shock, progressive multiple organ failure, and myelosuppression. Although many researchers in the world performed lots of research, there are currently no specific antidotes for colchicine poisoning. Meanwhile, there are no management guidelines to treat patients with acute colchicine poisoning until now. Herein, we systematically elaborate on the clinical features and progress in the management of acute colchicine poisoning in adults according to the previous literature. This paper will provide some valuable and available information for clinicians.

摘要

秋水仙碱是一种三环、脂溶性生物碱,长期以来一直被用于治疗痛风和许多免疫性疾病。由于其治疗窗狭窄和消除半衰期长,秋水仙碱过量的情况偶尔会发生。不幸的是,一些患者因秋水仙碱过量或自杀而失去生命。急性秋水仙碱中毒可导致原有胃肠道紊乱、休克、进行性多器官衰竭和骨髓抑制。尽管世界上许多研究人员进行了大量研究,但目前没有针对秋水仙碱中毒的特异性解毒剂。同时,到目前为止,还没有管理指南来治疗急性秋水仙碱中毒的患者。在此,我们根据以往文献系统阐述了成人急性秋水仙碱中毒的临床特征和治疗进展。本文将为临床医生提供一些有价值和可用的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/9417090/8bc8858c872e/11739_2022_3079_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验